Merck & Co (MRK) Shareholder James Investment Research Cut Its Stake as Market Valuation Rose; As Xpo Logistics (XPO) Market Valuation Rose, Holder Lonestar Capital Management Trimmed Position

June 14, 2018 - By Migdalia James

XPO Logistics, Inc. (NYSE:XPO) Logo

James Investment Research Inc decreased its stake in Merck & Co Inc (MRK) by 12.51% based on its latest 2018Q1 regulatory filing with the SEC. James Investment Research Inc sold 6,633 shares as the company’s stock rose 5.40% while stock markets declined. The institutional investor held 46,394 shares of the health care company at the end of 2018Q1, valued at $2.53 million, down from 53,027 at the end of the previous reported quarter. James Investment Research Inc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $165.62 billion market cap company. The stock decreased 0.89% or $0.55 during the last trading session, reaching $61.56. About 11.95M shares traded or 6.42% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 9.15% since June 14, 2017 and is downtrending. It has underperformed by 21.72% the S&P500. Some Historical MRK News: 08/03/2018 – STADA STAG.DE CEO SAYS IF MERCK WERE TO CHANGE DEAL STRUCTURE, VOLUME OF MERCK OTC BUSINESS FOR SALE, MAY THINK ABOUT IT; 16/05/2018 – Merck KGaA, Darmstadt, Germany Data at ASCO 2018 to Showcase Progress and Further Optionality of Oncology Pipeline; 24/03/2018 – ImmunoGen Presents Data from FORWARD II Assessment of Mirvetuximab Soravtansine in Combination with Pembrolizumab at the Societ; 27/03/2018 – ADVISORY-Alerts on Merck & Co’s fast-track designation for tepotinib withdrawn; 05/04/2018 – SIX ORGANIZATIONS ASK HHS TO LOWER ETEPLIRSEN DRUG PRICE; 27/03/2018 – MERCK & CO INC – JAPANESE MINISTRY OF HEALTH, LABOUR AND WELFARE GRANTS SAKIGAKE DESIGNATION FOR TEPOTINIB; 18/04/2018 – BRISTOL-MYERS SQUIBB – OPDIVO SUBMISSION BASED ON SAFETY AND EFFICACY DATA FROM SCLC COHORT OF PHASE 1/2 CHECKMATE -032 TRIAL; 08/03/2018 – Merck KGaA Updates on Consumer Health, New Launches — Earnings Review; 26/04/2018 – Bristol-Myers’ cancer drug Opdivo fuels growth, but revenue falls short; 23/05/2018 – STAT Plus: Soliticor General urges Supreme Court to review Merck case about warnings

Jerome L. Simon decreased its stake in Xpo Logistics Inc (XPO) by 20% based on its latest 2018Q1 regulatory filing with the SEC. Lonestar Capital Management Llc sold 45,000 shares as the company’s stock rose 9.70% while stock markets declined. The hedge fund run by Jerome L. Simon held 180,000 shares of the consumer services company at the end of 2018Q1, valued at $18.33 million, down from 225,000 at the end of the previous reported quarter. Lonestar Capital Management Llc who had been investing in Xpo Logistics Inc for a number of months, seems to be less bullish one the $13.47 billion market cap company. The stock decreased 1.45% or $1.64 during the last trading session, reaching $111.66. About 1.43 million shares traded. XPO Logistics, Inc. (NYSE:XPO) has risen 102.78% since June 14, 2017 and is uptrending. It has outperformed by 90.21% the S&P500. Some Historical XPO News: 02/05/2018 – XPO LOGISTICS 1Q ADJ EPS 61C, EST. 51C; 24/04/2018 – XPO LOGISTICS – LAUNCHED XPO DIRECT, A NEW, SHARED-SPACE DISTRIBUTION MODEL FOR OMNICHANNEL RETAIL & E-COMMERCE CUSTOMERS; 11/05/2018 – Ontario Teachers Adds Heico, Exits ADP, Cuts XPO Logistics: 13F; 30/04/2018 – Beutel Goodman Adds XPO Logistics, Exits K-Bro Linen: 13F; 23/04/2018 – REG-XPO Logistics Appoints Kenneth Wagers as Chief Operating Officer; 15/05/2018 – REG-XPO Logistics Named as a Leader in the Gartner Magic Quadrant for Third-Party Logistics Providers Worldwide; 09/05/2018 – Cramer also sits down with the CEOs of Etsy, XPO Logistics and Zebra Technologies; 06/03/2018 XPO LOGISTICS EUROPE SA XPO.PA – SIGNED NEW CONTRACT WITH SOPREMA; 08/03/2018 – Press Release: XPO Logistics Contract Logistics Site Reaches Safety Milestone; 21/04/2018 – DJ XPO Logistics Inc, Inst Holders, 1Q 2018 (XPO)

Among 24 analysts covering Merck & Co. Inc. (NYSE:MRK), 21 have Buy rating, 0 Sell and 3 Hold. Therefore 88% are positive. Merck & Co. Inc. had 90 analyst reports since August 13, 2015 according to SRatingsIntel. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Friday, July 28 by Piper Jaffray. The firm has “Buy” rating by Societe Generale given on Wednesday, April 6. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Goldman Sachs on Monday, April 23. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Market Perform” rating by Leerink Swann on Tuesday, February 6. The firm has “Outperform” rating by Credit Suisse given on Wednesday, August 30. BMO Capital Markets maintained the shares of MRK in report on Tuesday, July 4 with “Sell” rating. The firm has “Hold” rating given on Thursday, August 27 by Berenberg. Credit Suisse maintained the stock with “Neutral” rating in Monday, May 9 report. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Wednesday, July 19 by BMO Capital Markets. Cowen & Co maintained it with “Market Perform” rating and $68 target in Wednesday, April 12 report.

More notable recent Merck & Co., Inc. (NYSE:MRK) news were published by: Seekingalpha.com which released: “Bristol Meyers Top NASH Contenders” on June 12, 2018, also Streetinsider.com with their article: “Merck (MRK) Says FDA Granted Priority Review to its sBLA for GARDASIL9 in Women and Men Ages 27 to 45 for …” published on June 13, 2018, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma’s Q4 Miss, Sage Inks Deal With Japan’s …” on June 14, 2018. More interesting news about Merck & Co., Inc. (NYSE:MRK) were released by: 247Wallst.com and their article: “General Electric, JPMorgan Weaken the Dow Thursday” published on June 14, 2018 as well as 247Wallst.com‘s news article titled: “Merck Wins Another FDA Approval For Keytruda” with publication date: June 14, 2018.

Investors sentiment increased to 1 in Q1 2018. Its up 0.06, from 0.94 in 2017Q4. It increased, as 72 investors sold MRK shares while 603 reduced holdings. 114 funds opened positions while 561 raised stakes. 1.91 billion shares or 1.08% less from 1.93 billion shares in 2017Q4 were reported. Moreover, Gotham Asset Mgmt Ltd Limited Liability Company has 0.57% invested in Merck & Co., Inc. (NYSE:MRK). Panagora Asset Mngmt has 0.36% invested in Merck & Co., Inc. (NYSE:MRK). Spirit Of America Mgmt New York has invested 0.09% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Caprock invested in 30,848 shares. Fire Group has 5,767 shares. Everence Management Inc holds 0.71% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 58,706 shares. South Texas Money Mgmt owns 630,867 shares for 1.57% of their portfolio. Logan Cap Management stated it has 0.95% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Wms Ptnrs Ltd Liability Com reported 13,077 shares stake. Private Harbour Invest & Counsel Ltd Co has invested 0.8% in Merck & Co., Inc. (NYSE:MRK). Aureus Asset Limited Liability Co reported 0.12% stake. Murphy Pohlad Asset Lc owns 12,698 shares or 0.48% of their US portfolio. Nelson Roberts Invest Lc reported 3,660 shares or 0.05% of all its holdings. Da Davidson holds 0.72% or 636,935 shares. Birmingham Cap Management Co Al owns 70,569 shares or 1.59% of their US portfolio.

James Investment Research Inc, which manages about $5.64B and $2.66 billion US Long portfolio, upped its stake in Advanced Energy Industries (NASDAQ:AEIS) by 26,285 shares to 32,605 shares, valued at $2.08 million in 2018Q1, according to the filing. It also increased its holding in Nrg Energy Inc (NYSE:NRG) by 44,071 shares in the quarter, for a total of 181,323 shares, and has risen its stake in Ishares Barclays Tips Bond Fun (TIP).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on July, 27. They expect $1.04 EPS, up 2.97% or $0.03 from last year’s $1.01 per share. MRK’s profit will be $2.80B for 14.80 P/E if the $1.04 EPS becomes a reality. After $1.05 actual EPS reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -0.95% negative EPS growth.

More important recent XPO Logistics, Inc. (NYSE:XPO) news were published by: Investorplace.com which released: “XPO Logistics Inc Is an Unknown Stock That Should Be in Your Top 5” on May 25, 2018, also Fool.com published article titled: “3 Growth Stocks That Could Put Shopify’s Returns to Shame”, 247Wallst.com published: “Top Analyst Upgrades and Downgrades: Capital One, Hewlett Packard Enterprises, Kohl’s, Roku, Spotify, Steel …” on June 14, 2018. More interesting news about XPO Logistics, Inc. (NYSE:XPO) was released by: Fool.com and their article: “Is There a Speed Bump Ahead for XPO Logistics?” with publication date: June 13, 2018.

Among 21 analysts covering XPO Logistics (NYSE:XPO), 19 have Buy rating, 0 Sell and 2 Hold. Therefore 90% are positive. XPO Logistics had 80 analyst reports since August 7, 2015 according to SRatingsIntel. Cowen & Co maintained XPO Logistics, Inc. (NYSE:XPO) rating on Friday, November 3. Cowen & Co has “Buy” rating and $85.0 target. Oppenheimer maintained the stock with “Outperform” rating in Wednesday, November 11 report. Susquehanna maintained XPO Logistics, Inc. (NYSE:XPO) rating on Monday, January 8. Susquehanna has “Buy” rating and $112.0 target. The firm earned “Outperform” rating on Wednesday, September 30 by Oppenheimer. The rating was maintained by Stephens with “Hold” on Friday, February 9. The stock of XPO Logistics, Inc. (NYSE:XPO) has “Buy” rating given on Thursday, April 14 by Citigroup. On Friday, July 21 the stock rating was maintained by Citigroup with “Buy”. As per Friday, August 5, the company rating was maintained by Stifel Nicolaus. Citigroup maintained the shares of XPO in report on Wednesday, July 5 with “Buy” rating. The firm earned “Buy” rating on Tuesday, February 7 by Seaport Global Securities.

Analysts await XPO Logistics, Inc. (NYSE:XPO) to report earnings on August, 1. They expect $1.00 earnings per share, up 66.67% or $0.40 from last year’s $0.6 per share. XPO’s profit will be $120.64 million for 27.92 P/E if the $1.00 EPS becomes a reality. After $0.61 actual earnings per share reported by XPO Logistics, Inc. for the previous quarter, Wall Street now forecasts 63.93% EPS growth.

Investors sentiment decreased to 1.04 in Q1 2018. Its down 0.38, from 1.42 in 2017Q4. It dived, as 35 investors sold XPO shares while 136 reduced holdings. 75 funds opened positions while 102 raised stakes. 94.39 million shares or 4.39% less from 98.73 million shares in 2017Q4 were reported. 5,544 are held by Vident Invest Advisory Ltd Llc. 490,838 were reported by Mackay Shields Ltd Co. California-based Baker Avenue Asset Mgmt LP has invested 0.06% in XPO Logistics, Inc. (NYSE:XPO). Raymond James Trust Na reported 0.02% in XPO Logistics, Inc. (NYSE:XPO). Cedar Hill Associates Ltd holds 1.34% or 66,312 shares. L And S Advsr Inc holds 0.69% or 35,408 shares in its portfolio. Federated Pa owns 1.16M shares or 0.34% of their US portfolio. Tiger Eye Cap Lc owns 406,168 shares. Beach Point Management Lp holds 1.29% or 56,500 shares. 750 are owned by Whittier Of Nevada. Jane Street Gru Limited Liability Co invested in 0.01% or 42,369 shares. Td Asset Management, Ontario – Canada-based fund reported 30,000 shares. California-based Parallax Volatility Advisers Limited Partnership has invested 0% in XPO Logistics, Inc. (NYSE:XPO). Strs Ohio has 0.01% invested in XPO Logistics, Inc. (NYSE:XPO) for 17,000 shares. State Street Corporation owns 1.63M shares.

Lonestar Capital Management Llc, which manages about $310.91M US Long portfolio, upped its stake in Yamana Gold Inc (NYSE:AUY) by 800,000 shares to 2.00M shares, valued at $5.52 million in 2018Q1, according to the filing. It also increased its holding in Atlas Air Worldwide Hldgs In by 73,162 shares in the quarter, for a total of 180,002 shares, and has risen its stake in Ishares Tr (Put) (IWM).

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Migdalia James

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts